Search

everythinglearnresearchcommunity

for

Search:↓

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Melatonin may help treat PCOS symptoms in rats.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Photodynamic Therapy is an effective treatment for mild to severe acne.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.